SUCLA Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of SUCLA Antibodies for advanced research in the field of cellular metabolism. SUCLA Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SUCLA, or succinyl-CoA ligase, plays a critical role in the citric acid cycle, contributing to energy production and metabolic regulation. Its function is essential for maintaining cellular energy homeostasis and supporting various biosynthetic pathways. Dysregulation of SUCLA has been implicated in metabolic disorders, making it a significant target for research in understanding these conditions. Researchers can explore SUCLA's role in mitochondrial function and energy metabolism through detailed molecular studies. Advanced imaging techniques combined with SUCLA detection methods enable visualization of subcellular localization and protein interactions. Understanding SUCLA's involvement in metabolic pathways can lead to new therapeutic strategies for metabolic disorders. Santa Cruz Biotechnology monoclonal antibodies for SUCLA research support scientists worldwide in advancing our understanding of cellular metabolism and developing potential treatments for metabolic diseases.